Time filter

Source Type

Soares H.T.,University of Coimbra | Campos J.R.S.,University of Coimbra | Gomes-da-Silva L.C.,University of Coimbra | Schaberle F.A.,Luzitin SA Ed. Bluepharma 3045 016 Coimbra Portugal | And 2 more authors.
ChemBioChem | Year: 2016

Photodynamic therapy (PDT) uses light, photosensitizer molecules and oxygen to generate reactive oxygen species (ROS) that kill cancer cells. Redaporfin, a new photosensitizer in clinical trials, generates both singlet oxygen and superoxide ions. We report the potentiation of redaporfin-PDT in combination with ascorbate and with the inhibition of antioxidant enzymes in A549 (human lung adenocarcinoma) and CT26 (mouse colon adenocarcinoma) cells. The addition of ascorbate and the inhibition of superoxide dismutase (SOD) strongly increased the phototoxicity of redaporfin towards A549 cells but not towards CT26 cells. The inhibition of catalase and the depletion of the glutathione pool also potentiate redaporfin-PDT towards A549 cells. The lower SOD activity of A549 cells might explain this difference. SOD activity levels may be explored to increase the selectivity and efficacy of PDT with photosensitizers that generate radical species. © 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Loading Luzitin SA Ed. Bluepharma 3045 016 Coimbra Portugal collaborators
Loading Luzitin SA Ed. Bluepharma 3045 016 Coimbra Portugal collaborators